Silo Pharma, Inc.

Ownership Transactions Reported by 5 Insiders

Symbol
SILO on Nasdaq
Industry
Pharmaceutical Preparations
Location
677 N. Washington Blvd, Sarasota, FL

Insiders trading volume in the past year

Silo Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Eric Weisblum Chief Executive Officer, Director $77.4K +$12K +18.4% Nov 20, 2025
Daniel E. Ryweck Chief Financial Officer May 23, 2025
Wayne Linsley Director May 23, 2025
Jeff Pavell Director May 23, 2025
Kevin Munoz Director May 23, 2025

Recent Insider Transactions by Companies or Individuals for Silo Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.